Clinical Trial Update: Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg [Phase 3]

View source ↗

Summary

Phase 3 trial investigating a switch from telmisartan 80 mg plus hydrochlorothiazide to telmisartan 80 mg alone in patients who failed telmisartan 80 mg for hyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan 80 mg (telmisartan)
• Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED